SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
SI-BONE (Nasdaq: SIBN) will report fourth-quarter and full-year 2025 financial results after market close on February 23, 2026.
Rhea-AI Summary
SI-BONE (Nasdaq: SIBN) will report fourth-quarter and full-year 2025 financial results after market close on February 23, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET. A live webcast will be available on the company’s Investors page and archived for at least 90 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – SIBN
In the Feb 3 session, SIBN declined 0.67%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings release date
- February 23, 2026
- Q4 and full-year 2025 financial results release after market close
- Quarter end date
- December 31, 2025
- End of fourth quarter and full-year 2025 reporting period
- Conference call time PT
- 1:30 p.m. Pacific Time
- Scheduled start of earnings conference call
- Conference call time ET
- 4:30 p.m. Eastern Time
- Scheduled start of earnings conference call
- Webcast replay period
- 90 days
- Archived earnings call webcast available for replay
Historical Context
-
Preliminary Q4 and FY 2025 revenue and cash figures with solid growth.
-
Announcement of presentation at Piper Sandler healthcare conference with webcast.
-
Strong Q3 revenue growth, margin expansion, positive EBITDA, raised guidance.
-
Q2 revenue growth over 21% YoY and improved profitability metrics and guidance.
-
Notification of Q3 2025 earnings release timing and conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the fourth quarter and full year ended December 31, 2025 after market close on Monday, February 23, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/zfxy6yox. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is the global leader in developing procedural solutions to address clinical challenges associated with compromised bone. SI-BONE's expertise in additive manufacturing has resulted in a technology platform with market-leading applications in SI joint fusion, adult spinal deformity and pelvic trauma. Since 2009, SI-BONE has supported physicians in performing a total of over 140,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including four randomized controlled trials and over 200 peer reviewed publications.
For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.
SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved.
Marnelli.delcastillo@si-bone.com
650-271-7515
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.